{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:43:50Z","timestamp":1768290230219,"version":"3.49.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\nBackground<\/jats:title>\nRheumatoid arthritis (RA) patients commonly report medicinal cannabis use (MCU). Personality has been independently associated with both RA-related outcomes and MCU, but there is no information available on how they interact in RA patients. This study aimed to investigate a potential association between personality traits and MCU in RA outpatients, as well as to identify additional factors associated with its use.<\/jats:p>\n<\/jats:sec>\n\nMethods<\/jats:title>\nThis cross-sectional study was performed between June 2020 and August 2021. Consecutive RA outpatients had standardized evaluations using an interview format to collect sociodemographic information, comorbidities, risk of recreational substance use, RA-related disease activity\/severity, health-related quality of life, depressive and anxiety symptoms, five personality traits, and MCU in the 12 months before the interview. Multivariable logistic regression estimated adjusted odds ratios (aOR). The study was IRB-approved.<\/jats:p>\n<\/jats:sec>\n\nResults<\/jats:title>\n180 patients were included; 160 (88.9%) were women with a mean age of 53.4 \u00b1 13 years. Fifty-three (29.4%) patients reported MCU. Among them, 52 (98.1%) used topical formulations. Neuroticism had the highest overall score (x<\/mml:mi><\/mml:mrow>\u00af<\/mml:mo><\/mml:mover><\/mml:math><\/jats:alternatives><\/jats:inline-formula> = 3.47 \u00b1 0.34). Openness to experience trait was higher in MCU patients in the comparative analysis (p = 0.007). In the multivariable regression, higher openness trait (aOR: 2.81, 95%CI: 1.11\u20137.10) along with moderate risk in tobacco use (aOR: 3.36, 95%CI: 1.04\u201310.7) and higher RA disease activity\/severity (aOR: 1.10, 95%CI: 1.01\u20131.19) were independently associated with MCU.<\/jats:p>\n<\/jats:sec>\n\nConclusions<\/jats:title>\nIn the current study, personality influenced the seeking of MCU for pain relief, associating dynamically with higher disease activity\/severity and tobacco use. Contrary to other available information, it did not relate to psychopathology or the recreational use of cannabis. Proactive interdisciplinary clinical evaluations around MCU in RA outpatients should include personality, besides standard clinical assessments, to understand patients\u2019 motivations for its use as they may reveal important clinical information.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0280219","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T18:45:58Z","timestamp":1673549158000},"page":"e0280219","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-4192","authenticated-orcid":true,"given":"Jos\u00e9 R.","family":"Galindo-Donaire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Hern\u00e1ndez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Fres\u00e1n Orellana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraz\u00fa","family":"Contreras-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Guaracha-Bas\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswaldo","family":"Brise\u00f1o-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7368-498X","authenticated-orcid":true,"given":"Virginia","family":"Pascual-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"pone.0280219.ref001","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"JS Smolen","year":"2016","journal-title":"The Lancet"},{"key":"pone.0280219.ref002","first-page":"1248","article-title":"Consequences of rheumatoid arthritis for performance of social roles\u2014a literature review","volume":"34","author":"GA Geuskens","year":"2007","journal-title":"J Rheumatol"},{"key":"pone.0280219.ref003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2020.11.003","article-title":"Traditional and modern management strategies for rheumatoid arthritis","volume":"512","author":"M Akram","year":"2021","journal-title":"Clin Chim Acta"},{"key":"pone.0280219.ref004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1742-1241.2004.00271.x","article-title":"The medicinal use of cannabis in the UK: results of a nationwide survey","volume":"59","author":"MA Ware","year":"2005","journal-title":"Int J Clin Pract"},{"key":"pone.0280219.ref005","doi-asserted-by":"crossref","first-page":"e0237504","DOI":"10.1371\/journal.pone.0237504","article-title":"Association of significant risk perception with the use of complementary and alternative medicine: A cross-sectional study in Hispanic patients with rheumatoid arthritis","volume":"15","author":"I Contreras-Y\u00e1\u00f1ez","year":"2020","journal-title":"PLoS One"},{"key":"pone.0280219.ref006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13075-022-02884-w","article-title":"Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis","volume":"24","author":"I Contreras-Y\u00e1\u00f1ez","year":"2022","journal-title":"Arthritis Res Ther."},{"key":"pone.0280219.ref007","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/acm.2017.0184","article-title":"Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses","volume":"24","author":"D Bruce","year":"2018","journal-title":"J Altern Complement Med"},{"key":"pone.0280219.ref008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/eci.12.23","article-title":"Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature","volume":"8","author":"BJF van den Bemt","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"pone.0280219.ref009","first-page":"748","article-title":"Persistence on therapy is a major determinant of patient-, physician- and laboratory- reported outcomes in recent-onset rheumatoid arthritis patients","volume":"28","author":"I Contreras-Y\u00e1\u00f1ez","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"pone.0280219.ref010","volume-title":"Encyclopedia of psychology.","author":"AE Kazdin","year":"2000"},{"key":"pone.0280219.ref011","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.ps.41.020190.002221","article-title":"Personality Structure: Emergence of the Five-Factor Model","volume":"41","author":"JM Digman","year":"1990","journal-title":"Annu. Rev. Psychol"},{"key":"pone.0280219.ref012","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1037\/0022-3514.75.3.729","article-title":"Los Cinco Grandes across cultures and ethnic groups: multitrait multimethod analyses of the Big Five in Spanish and English","volume":"75","author":"V Benet-Mart\u00ednez","year":"1998","journal-title":"J Pers Soc Psychol"},{"key":"pone.0280219.ref013","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/B978-012134645-4\/50032-9","volume-title":"Handbook of personality psychology","author":"RR McCrae","year":"1997"},{"key":"pone.0280219.ref014","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/geronb\/gbt036","article-title":"Personality traits and chronic disease: implications for adult personality development","volume":"68","author":"AR Sutin","year":"2013","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"pone.0280219.ref015","first-page":"1118","article-title":"Determinants of happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach","volume":"77","author":"EJF Santos","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"pone.0280219.ref016","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00296-016-3561-9","article-title":"Influence of patient personality in the treatment of rheumatoid arthritis","volume":"36","author":"L Leon","year":"2016","journal-title":"Rheumatol Int."},{"key":"pone.0280219.ref017","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3349\/ymj.2020.61.5.406","article-title":"Contribution of Personality Traits, Psychological Factors, and Health-Related Quality of Life to Medication Adherence in Patients with Rheumatoid Arthritis","volume":"61","author":"KM Ko","year":"2020","journal-title":"Yonsei Med J."},{"key":"pone.0280219.ref018","article-title":"Experiences of self-care during the COVID-19 pandemic among individuals with rheumatoid arthritis: A qualitative study","author":"J Leese","year":"2021","journal-title":"Health Expect"},{"key":"pone.0280219.ref019","first-page":"51","article-title":"Associations of personality traits with marijuana use in a nationally representative sample of adolescents in the United States","volume":"8","author":"AE Lee-Winn","year":"2018","journal-title":"Addict Behav Rep"},{"key":"pone.0280219.ref020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1037\/1064-1297.10.4.425","article-title":"The relations among personality, symptoms of alcohol and marijuana abuse, and symptoms of comorbid psychopathology: results from a community sample","volume":"10","author":"K Flory","year":"2002","journal-title":"Exp Clin Psychopharmacol."},{"key":"pone.0280219.ref021","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psychres.2010.07.035","article-title":"Cannabis users differ from non-users on measures of personality and schizotypy","volume":"186","author":"DJ Fridberg","year":"2011","journal-title":"Psychiatry Res"},{"key":"pone.0280219.ref022","doi-asserted-by":"crossref","first-page":"e0233463","DOI":"10.1371\/journal.pone.0233463","article-title":"Characterizing motivations for cannabis use in a cohort of people who use illicit drugs: A latent class analysis","volume":"15","author":"S Lake","year":"2020","journal-title":"PLoS One"},{"key":"pone.0280219.ref023","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/157340007781369658","article-title":"Cannabis Use, First-Episode Psychosis, and Schizotypy: A Summary and Synthesis of Recent Literature","volume":"3","author":"MT Compton","year":"2007","journal-title":"CPSR"},{"key":"pone.0280219.ref024","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jamapsychiatry.2015.3229","article-title":"Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study","volume":"73","author":"C Blanco","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"pone.0280219.ref025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s40429-018-0214-y","article-title":"Cannabis and Mood Disorders","volume":"5","author":"AM Lucatch","year":"2018","journal-title":"Curr Addict Rep."},{"key":"pone.0280219.ref026","doi-asserted-by":"crossref","first-page":"491","DOI":"10.17711\/SM.0185-3325.2014.059","article-title":"Psychometric properties of the big five inventory in a Mexican sample (Propiedades psicom\u00e9tricas del Inventario de los Cinco Grandes en una muestra mexicana)","volume":"37","author":"E Reyes Zamorano","year":"2014","journal-title":"Salud Ment"},{"key":"pone.0280219.ref027","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1046\/j.1360-0443.2002.00185.x","article-title":"The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility","volume":"97","author":"WHO ASSIST Working Group","year":"2002","journal-title":"Addiction"},{"key":"pone.0280219.ref028","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3899\/jrheum.080182","article-title":"RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories","volume":"35","author":"T Pincus","year":"2008","journal-title":"J Rheumatol"},{"key":"pone.0280219.ref029","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1529-0131(200104)45:2<167::AID-ANR170>3.0.CO;2-X","article-title":"An English and Spanish quality of life measure for rheumatoid arthritis","volume":"45","author":"LL Danao","year":"2001","journal-title":"Arthritis & Rheumatism"},{"key":"pone.0280219.ref030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"K Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"pone.0280219.ref031","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"RL Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"pone.0280219.ref032","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"J Busner","year":"2007","journal-title":"Psychiatry (Edgmont)."},{"key":"pone.0280219.ref033","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"M Charlson","year":"1994","journal-title":"Journal of Clinical Epidemiology"},{"key":"pone.0280219.ref034","volume-title":"Statistical power analysis for the behavioral sciences.","author":"J. Cohen","year":"1988","edition":"2"},{"key":"pone.0280219.ref035","first-page":"111","article-title":"A primer on model selection using the Akaike Information Criterion","volume":"5","author":"S. Portet","year":"2020","journal-title":"Infect Dis Model"},{"key":"pone.0280219.ref036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7517-2-18","article-title":"Survey of Australians using cannabis for medical purposes","volume":"2","author":"W Swift","year":"2005","journal-title":"Harm Reduct J"},{"key":"pone.0280219.ref037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s42238-021-00096-8","article-title":"Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions","volume":"3","author":"D Furrer","year":"2021","journal-title":"J Cannabis Res"},{"key":"pone.0280219.ref038","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/j.pain.0000000000000706","article-title":"Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis","volume":"157","author":"PA Ste-Marie","year":"2016","journal-title":"Pain"},{"key":"pone.0280219.ref039","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/acr2.11138","article-title":"Medical Cannabis Use by Rheumatology Patients Following Recreational Legalization: A Prospective Observational Study of 1000 Patients in Canada","volume":"2","author":"M-A Fitzcharles","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"pone.0280219.ref040","doi-asserted-by":"crossref","first-page":"e0257319","DOI":"10.1371\/journal.pone.0257319","article-title":"Prevalence of complementary and alternative medicine despite limited perceived efficacy in patients with rheumatic diseases in Mexico: Cross-sectional study","volume":"16","author":"CI Caballero-Hern\u00e1ndez","year":"2021","journal-title":"PLoS One"},{"key":"pone.0280219.ref041","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/art.1790110513","article-title":"Use of alternative therapies by patients with rheumatic disease in Guadalajara, Mexico: prevalence, beliefs, and expectations","volume":"11","author":"C Ramos-Remus","year":"1998","journal-title":"Arthritis Care Res"},{"key":"pone.0280219.ref042","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jbspin.2016.03.006","article-title":"Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseases","volume":"84","author":"E Bucourt","year":"2017","journal-title":"Joint Bone Spine"},{"key":"pone.0280219.ref043","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1017\/S0033291714000257","article-title":"Personality change associated with chronic diseases: pooled analysis of four prospective cohort studies","volume":"44","author":"M Jokela","year":"2014","journal-title":"Psychol Med"},{"key":"pone.0280219.ref044","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/s41467-018-05859-1","article-title":"Brain and psychological determinants of placebo pill response in chronic pain patients","volume":"9","author":"E Vachon-Presseau","year":"2018","journal-title":"Nat Commun"},{"key":"pone.0280219.ref045","first-page":"212","article-title":"Normalization and denormalization in different legal contexts: Comparing cannabis and tobacco","volume":"23","author":"M Asbridge","year":"2016","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"pone.0280219.ref046","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctim.2004.09.006","article-title":"Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies","volume":"12","author":"A Robinson","year":"2004","journal-title":"Complement Ther Med"},{"key":"pone.0280219.ref047","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2147\/JPR.S323568","article-title":"The Impact of the First Wave of the COVID-19 Pandemic on Patients\u2019 Perceptions of Chronic Pain","volume":"14","author":"ME Smyrnioti","year":"2021","journal-title":"J Pain Res"},{"key":"pone.0280219.ref048","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/da.20026","article-title":"Anxiety and depressive disorders and the five-factor model of personality: a higher- and lower-order personality trait investigation in a community sample","volume":"20","author":"OJ Bienvenu","year":"2004","journal-title":"Depress Anxiety"},{"key":"pone.0280219.ref049","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/ptr.6639","article-title":"Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study","volume":"34","author":"JC Bouso","year":"2020","journal-title":"Phytother Res"},{"key":"pone.0280219.ref050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40429-020-00334-8","article-title":"Treatment Implications Associated with Cannabis and Tobacco Co-Use","volume":"7","author":"EA McClure","year":"2020","journal-title":"Curr Addict Rep"},{"key":"pone.0280219.ref051","doi-asserted-by":"crossref","first-page":"108481","DOI":"10.1016\/j.jsat.2021.108481","article-title":"Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in Canada","volume":"130","author":"P Lucas","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"pone.0280219.ref052","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpsychires.2015.02.008","article-title":"Big five personality factors and cigarette smoking: a 10-year study among US adults","volume":"63","author":"MJ Zvolensky","year":"2015","journal-title":"J Psychiatr Res"},{"key":"pone.0280219.ref053","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10067-016-3521-5","article-title":"Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis","volume":"36","author":"JGB Mu\u00f1oz","year":"2017","journal-title":"Clin Rheumatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T18:46:45Z","timestamp":1673549205000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280219"}},"subtitle":[],"editor":[{"given":"Christine","family":"Nardini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0280219","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}